First Study to Track Individual Collagen Peptides Through the Body Reveals Surprisingly Low Absorption | Research

The takeaway

Individual pharmacokinetic profiling showed collagen tripeptide Gly-Pro-Hyp has only 4.4% oral bioavailability while dipeptide Pro-Hyp achieves 19.3%, with flip-flop kinetics suggesting transporter-mediated slow absorption.

4.4% to 19.3% oral bioavailability
Only a small fraction of ingested collagen peptides reach the bloodstream — the tripeptide Gly-Pro-Hyp at 4.4% and dipeptide Pro-Hyp at 19.3% in rats

What the researchers found

First individual PK profiling of collagen peptides shows Gly-Pro-Hyp has 4.4% oral bioavailability and Pro-Hyp has 19.3%, with flip-flop kinetics indicating transporter-mediated absorption and double-peak patterns suggesting multiple absorption sites.

Why it matters

Millions of people take collagen supplements, but the fundamental question of how much actually reaches the bloodstream was unanswered until now. This study provides the first rigorous pharmacokinetic data for individual collagen peptides, showing that absorption is low and peptide-specific — information essential for rational dosing.

The numbers in context

IV dose: 5 mg/kg. Oral dose: 100 mg/kg. Oral bioavailability ranged from ~18% to ~39%. Pro-Hyp showed highest absorption.

How the study worked

Rats received individual collagen peptides (Gly-Pro-Hyp, Pro-Hyp, Gly-Pro) via IV (5 mg/kg) and intragastric (100 mg/kg) routes. Plasma levels and urinary excretion were measured by LC-MS/MS. Pharmacokinetic parameters including absolute oral bioavailability, Cmax, Tmax, and elimination rates were calculated.

Who was studied

Rats (pharmacokinetic study)

What this study cannot tell us

Rat pharmacokinetics — human absorption may differ significantly due to differences in gut transporters, pH, and transit time. Individual peptides were given in isolation, while collagen supplements contain complex mixtures where peptides may compete for transporters. The doses used (100 mg/kg oral) are high relative to typical human supplement doses. The biological significance of the small absorbed fraction is not addressed.

How to read the evidence

Preliminary evidence from a rigorous pharmacokinetic study in rats. First-of-its-kind data for individual collagen peptides, but translation to human absorption requires dedicated clinical PK studies.

When this study was published

Published in 2024, filling a surprising gap in our understanding of one of the most popular supplement categories.

The bigger picture

The collagen supplement market is worth billions, but scientific understanding of what these products actually do in the body is still catching up. This PK study provides critical baseline data: even the best-absorbed collagen peptide (Pro-Hyp) has less than 20% bioavailability, meaning most of what you swallow never reaches the bloodstream. This information should guide supplement dosing, formulation development, and help explain why clinical trial results for collagen supplements have been mixed.

Questions still open

Is the 4-19% that reaches the bloodstream sufficient to produce the clinical benefits claimed for collagen supplements?
Do human absorption rates differ significantly from these rat data?
Could formulation strategies (enteric coating, absorption enhancers) improve collagen peptide bioavailability?

Common questions

Does this mean collagen supplements don't work?

Not necessarily. Low bioavailability doesn't mean no effect — even the absorbed fraction could be biologically active. Pro-Hyp at 19.3% bioavailability means a meaningful amount does reach the blood. Some clinical trials have shown benefits of collagen supplements for skin, joints, and bones. However, these PK data suggest that much of what you take is broken down in the gut, and effective doses may need to be higher than many products provide.

What is flip-flop kinetics and why does it matter for collagen peptides?

Normally, drugs clear from the blood more slowly than they're absorbed (you take a pill, levels rise quickly, then slowly fall). 'Flip-flop' means the opposite — the collagen peptides clear from blood faster than they're absorbed. This suggests they enter the bloodstream slowly through specialized transporters in the gut wall, not by simple passive diffusion. It matters because it means you can't speed up absorption by taking more — the transporters are the bottleneck.

Read the original research

Pharmacokinetics of collagen dipeptides (Gly-Pro and Pro-Hyp) and tripeptides (Gly-Pro-Hyp) in rats.

Journal of food science, 89(1), 701-709

View on PubMed ↗Publisher’s paper ↗

Citation

Won, Jihyun; Kang, Juhyung; Noh, Keumhan; Chung, Hee-Chul; Kang, Wonku. (2024). Pharmacokinetics of collagen dipeptides (Gly-Pro and Pro-Hyp) and tripeptides (Gly-Pro-Hyp) in rats.. Journal of food science, 89(1), 701-709. https://doi.org/10.1111/1750-3841.16871